Front Row Advisors’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-81
Closed -$2K 921
2022
Q2
$2K Buy
81
+10
+14% +$299 ﹤0.01% 807
2022
Q1
$3K Hold
71
﹤0.01% 797
2021
Q4
$5K Sell
71
-6
-8% -$529 ﹤0.01% 735
2021
Q3
$7K Hold
77
﹤0.01% 647
2021
Q2
$8K Hold
77
﹤0.01% 615
2021
Q1
$7K Sell
77
-22
-22% -$2.42K ﹤0.01% 628
2020
Q4
$10K Hold
99
0.01% 517
2020
Q3
$9K Buy
99
+42
+74% +$2.02K ﹤0.01% 529
2020
Q2
$2K Buy
+57
New +$1.64K ﹤0.01% 825

Other funds holding CRNC

Front Row Advisors's CRNC Position: Q3 2022 in Review

Front Row Advisors sold out of Cerence (CRNC) in Q3 2022, closing a stake of 81 shares — an estimated $2K sold.

Front Row Advisors first reported a position in CRNC in Q2 2020 and held it in 9 quarters. The position peaked at $10K in Q4 2020. 230 funds tracked by Wall St. Rank hold CRNC as of Q3 2022.

  • Front Row Advisors reported no remaining Cerence position as of Q3 2022 after selling out during the quarter.
  • Front Row Advisors sold 81 Cerence shares in Q3 2022, an estimated $2K.
  • Front Row Advisors first reported a position in Cerence in Q2 2020 and held it in 9 quarters.
  • Front Row Advisors's Cerence position peaked at $10K in Q4 2020.
  • 230 funds tracked by Wall St. Rank held Cerence as of Q3 2022.

Based on Front Row Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.